Join the Anaphylaxis group to help and get support from people like you.
Anaphylaxis News (Page 4)
Related terms: Anaphylactic Reaction, Anaphylactic Shock, Shock, Anaphylactic
Researchers Use EHR Systems to ID Pediatric Allergy Patterns
TUESDAY, Aug. 1, 2023 – In a study published online July 25 in Pediatrics, the authors describe pediatric allergy patterns across the United States. Stanislaw J. Gabryszewski, M.D., Ph.D., from the...
More Parents Are Introducing Peanuts Early
MONDAY, July 31, 2023 – Early peanut feeding practices are gaining traction among U.S. parents/caregivers, according to a study published online July 21 in Pediatrics. Waheeda Samady, M.D., from the...
Direct Oral Penicillin Challenge Noninferior to Standard of Care
TUESDAY, July 25, 2023 – For patients with low-risk penicillin allergy, direct oral penicillin challenge is noninferior to standard-of-care skin testing followed by oral challenge, according to a...
FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 31, 2020-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...
FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Richmond, VA (November 20, 2017) kaléo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application ...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEP...
FDA Medwatch Alert: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
ISSUE: Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (...
FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...
Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
PARIS, Aug. 13, 2012 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Audi-Q (epinephrine injection, USP) for the emergency treatment of...
Ask a question
To post your own question to this support group, sign in or create an account.